Condensed Balance Sheet (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
ASSETS
Cash	$ 76,098	$ 458,233
Receivable from stockholders	35,000	35,000
Deferred offering cost	5,065,000	3,902,000
Total assets	5,176,098	4,395,233
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	5,096,805	4,006,062
Total liabilities	5,096,805	4,006,062
Stockholders’ (deficit) equity
Common stock, $0.01 par value; authorized– 50,000,000 shares; 2,939,130 and 2,939,130 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	29,391	29,391
Additional paid in capital	932,609	932,609
Retained deficit	(882,707)	(572,829)
Total stockholders’ equity	79,293	389,171
Total liabilities and stockholders’ equity	$ 5,176,098	$ 4,395,233